BCL2 and acute myeloid leukemia: VEN inhibits the anti-apoptotic activity of the transcription factor NF-κB and suppresses BCL2, which selectively sequesters the apoptotic protein BAX, thereby targeting the anti-apoptotic pathways observed in NPM1-mutated AML (35, 36).